Single center experience with Voretigene Neparvovec gene augmentation therapy in RPE65-mutation associated inherited retinal degeneration (vol 2, pg 161, 2024)

被引：0
|
作者：
Lorenz, Birgit
Kunzel, Sandrine H.
Preising, Markus N.
Scholz, Johanna P.
Chang, Petrus
Holz, Frank G.
Herrmann, Philipp
机构：
来源：
OPHTHALMOLOGY | 2024年 / 131卷 / 06期
关键词：
D O I：
10.1016/j.ophtha.2024.02.021
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：744 / 744
页数：1
相关论文
共 26 条
  • [1] Single Center Experience with Voretigene Neparvovec Gene Augmentation Therapy in RPE65 Mutation-Associated Inherited Retinal Degeneration in a Clinical Setting
    Lorenz, Birgit
    Kuenzel, Sandrine H.
    Preising, Markus N.
    Scholz, Johanna P.
    Chang, Petrus
    Holz, Frank G.
    Herrmann, Philipp
    OPHTHALMOLOGY, 2024, 131 (02) : 161 - 178
  • [2] Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy
    Kang, Connie
    Scott, Lesley J.
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (04) : 487 - 495
  • [3] Voretigene Neparvovec: A Review in RPE65 Mutation-Associated Inherited Retinal Dystrophy
    Connie Kang
    Lesley J. Scott
    Molecular Diagnosis & Therapy, 2020, 24 : 487 - 495
  • [4] Functional benefits of subretinal gene augmentation therapy with Voretigene Neparvovec for inherited retinal disease associated with biallelic mutations in RPE65
    Lorenz, Birgit
    Preising, Markus N.
    Scholz, Johanna Pauline
    Kuenzel, Sandrine H.
    Herrmann, Philipp
    Holz, Frank G.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [5] Longitudinal characterization of chorioretinal atrophies after subretinal gene augmentation therapy with Voretigene Neparvovec in RPE65-mediated retinal degeneration
    Kuenzel, Sandrine
    Sassmannshausen, Marlene
    Sassen, Josua
    Preising, Markus
    Holz, Frank
    Lorenz, Birgit
    Herrmann, Philipp
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [6] RPE65-associated retinal dystrophies: phenotypes and treatment effects with voretigene neparvovec (vol 241, pg 259, 2024)
    Stingl, Katarina
    Priglinger, Claudia
    Herrmann, Philipp
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2024, 241 (03) : e1 - e1
  • [7] Prospective study on safety and efficacy of gene therapy with voretigene neparvovec in patients with RPE65-associated inherited retinal degenerations
    van den Born, L. I.
    Talsma, H. E.
    van Genderen, M. M.
    van Schooneveld, M. J.
    Crama, N.
    de Hoog, J.
    Yzer, S.
    Maning, S.
    Faridpooya, K.
    Hoyng, C. B.
    Boon, C. J. F.
    van Overdam, K. A.
    ACTA OPHTHALMOLOGICA, 2022, 100 : 20 - 20
  • [8] Prospective-up study on safety and efficacy of gene therapy with voretigene neparvovec in patients with RPE65-associated inherited retinal degenerations
    van den, L. I.
    Talsma, H. E.
    van Genderen, M. M.
    Smailhodzic, D.
    van Schooneveld, M. J.
    Crama, N.
    de Hoog, J.
    Hoyng, C. B.
    Manning, S. S.
    Faridpooya, K.
    Yzer, S.
    Boon, C. J. F.
    van Overdam, K. A.
    ACTA OPHTHALMOLOGICA, 2023, 101 : 16 - 16
  • [9] Prospect of retinal gene therapy following commercialization of voretigene neparvovec-rzyl for retinal dystrophy mediated by RPE65 mutation
    Ameri, Hossein
    JOURNAL OF CURRENT OPHTHALMOLOGY, 2018, 30 (01): : 1 - 2
  • [10] Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development
    Ciulla, Thomas A.
    Hussain, Rehan M.
    Berrocal, Audina M.
    Nagiel, Aaron
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (06) : 565 - 578
123